Hamilton and Biosero Announce Co-Marketing Agreement to Optimize Automated Liquid Handling Workflows
RENO, Nev. & SAN DIEGO--(BUSINESS WIRE)--Hamilton and Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a strategic co-marketing ...
Collaboration integrates the nRichDX Revolution Plus™ Sample Prep System with the Hamilton Microlab STAR ® platform, delivering automated, high-yield liquid biopsy workflows for cfDNA, cfRNA, cfTNA, ...
NATICK, Mass., Feb. 18, 2025 /PRNewswire/ -- Pillar Biosciences, Inc., the leader in Decision Medicine™, has entered into a strategic NGS automation application development agreement and co-marketing ...
SAN DIEGO, Sept. 27, 2022 /PRNewswire/ -- Biofluidica, Inc., and Hamilton Company, today announced a co-marketing agreement to bring advanced Liquid Biopsy capabilities to laboratories worldwide.
Automated liquid handling, has become an essential feature of laboratories across a broad range of disciplines, helping to increase laboratory capacity and improve the quality or reproducibility of ...
The MarketWatch News Department was not involved in the creation of this content. Collaboration integrates the nRichDX Revolution Plus(TM) Sample Prep System with the Hamilton Microlab STAR(R) ...
The integrated solution delivers an automated, end-to-end workflow for isolating circulating cell-free DNA (cfDNA), circulating cell-free RNA (cfRNA), circulating cell-free total nucleic acid (cfTNA), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results